Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/08/17
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 02/15/21
End: 10/30/22
Due: 10/30/23
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/06/16
End: 03/22/18
Due: 03/22/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older | NCT03074266 | Accriva Diagnostics | user2@example.com | None | 2017-06-08 | 2018-12-31 | 2019-12-31 | - | - | 2025-07-14 |
| Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan | NCT03615846 | Accriva Diagnostics | user2@example.com | None | 2021-02-15 | 2022-10-30 | 2023-10-30 | - | - | 2025-07-14 |
| Clinical Performance of Investigational InRhythm PT/INR System in a Professional Use Setting | NCT02586818 | Accriva Diagnostics | user2@example.com | None | - | - | - | - | - | 2025-07-14 |
| VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study | NCT04492423 | Accriva Diagnostics | user2@example.com | None | 2016-09-06 | 2018-03-22 | 2019-03-22 | - | - | 2025-07-14 |